Apimeds Pharmaceuticals US stockAPUS
Apimeds Pharmaceuticals US trades at $2.73, 93.2% below its 52-week high (Nov 17, 2025). The price is below its 50- and 200-day averages, a downtrend. −83.4% year to date, −90.0% over 12 months (S&P 500 over the same period: +8.8%).
Ratings, candles, signals and the screener for APUS — after you log in
Open the terminalFrequently asked questions about Apimeds Pharmaceuticals US
What is the Apimeds Pharmaceuticals US stock price?
At the close on Nov 5, 2026: $2.73 (−6.51% on the day). 52-week high: $40.31 on Nov 17, 2025. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
Does Apimeds Pharmaceuticals US pay dividends?
No, Apimeds Pharmaceuticals US does not pay dividends.
Where does Apimeds Pharmaceuticals US trade and how to buy it?
Ticker APUS, exchange NYSE American, listed since 2025. You can buy it through a broker with access to US exchanges.
Should I buy Apimeds Pharmaceuticals US now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for APUS are in the terminal after you log in.